Christine Garrett
Corporate Officer/Principal en LEO Pharma A/S .
Perfil
Christine Garrett is currently the Vice President & Head-Global Project Management at LEO Pharma A.
Previously, she held the position of Head-Late Development Project Management at Bristol Myers Squibb Co. and Chief of Staff & Senior Vice President-Operations at Graphite Bio, Inc. She holds a doctorate degree from the Massachusetts Institute of Technology and an undergraduate degree from the Rochester Institute of Technology.
Cargos activos de Christine Garrett
Empresas | Cargo | Inicio |
---|---|---|
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Christine Garrett.
Empresas | Cargo | Fin |
---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
LENZ THERAPEUTICS, INC. | Chief Operating Officer | - |
Formación de Christine Garrett.
Massachusetts Institute of Technology | Doctorate Degree |
Rochester Institute of Technology | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Empresas privadas | 2 |
---|---|
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Health Technology |
Graphite Bio, Inc.
Graphite Bio, Inc. BiotechnologyHealth Technology Graphite Bio, Inc. is a clinical-stage gene editing company. It engages in the business of developing therapies that harness targeted gene integration to treat or cure serious diseases. The company was founded by Matthew Porteus and Maria Grazia Roncarolo on June 1, 2017 and is headquartered in South San Francisco, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Christine Garrett